Screener
ProShares UltraPro Short NASDAQ Biotechnology ZBIO Q3 2025 earnings
Reported November 12, 2025 · Before market open
EPS-$1.22Miss by $0.35
Revenue estimate$28.8M
EPS estimate-$0.87
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$1.0M
EPS estimate-$1.22
Versus estimates
FAQ
- When did ProShares UltraPro Short NASDAQ Biotechnology report Q3 2025 earnings?
- ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were ProShares UltraPro Short NASDAQ Biotechnology's Q3 2025 revenue and EPS?
- ProShares UltraPro Short NASDAQ Biotechnology reported eps of $-1.22 for Q3 2025.
- Did ProShares UltraPro Short NASDAQ Biotechnology beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.87 by $0.35.
- How did ProShares UltraPro Short NASDAQ Biotechnology's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 75.7% from $-5.02.
- Where can I find ProShares UltraPro Short NASDAQ Biotechnology's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-109737) and the 10-Q periodic report (0001104659-25-109753) directly on SEC EDGAR. The filing index links above go to sec.gov.
